Department of Medicine, UCSF, San Francisco, California, USA.
J Clin Invest. 2013 Sep;123(9):3728-39. doi: 10.1172/JCI68182. Epub 2013 Aug 8.
Hepatitis B virus (HBV) is a major human pathogen that causes immune-mediated hepatitis. Successful immunity to HBV is age dependent: viral clearance occurs in most adults, whereas neonates and young children usually develop chronic infection. Using a mouse model of HBV infection, we sought mechanisms underpinning the age-dependent outcome of HBV and demonstrated that hepatic macrophages facilitate lymphoid organization and immune priming within the adult liver and promote successful immunity. In contrast, lymphoid organization and immune priming was greatly diminished in the livers of young mice, and of macrophage-depleted adult mice, leading to abrogated HBV immunity. Furthermore, we found that CXCL13, which is involved in B lymphocyte trafficking and lymphoid architecture and development, is expressed in an age-dependent manner in both adult mouse and human hepatic macrophages and plays an integral role in facilitating an effective immune response against HBV. Taken together, these results identify some of the immunological mechanisms necessary for effective control of HBV.
乙型肝炎病毒 (HBV) 是一种主要的人类病原体,可引起免疫介导的肝炎。对 HBV 的成功免疫具有年龄依赖性:大多数成年人可清除病毒,而新生儿和幼儿通常会发展为慢性感染。我们使用乙型肝炎病毒感染的小鼠模型,研究了 HBV 年龄依赖性结果的潜在机制,并证明肝巨噬细胞有助于成年肝脏中的淋巴组织形成和免疫启动,并促进了成功的免疫。相比之下,幼年小鼠和巨噬细胞耗竭的成年小鼠的肝脏中淋巴组织形成和免疫启动大大减少,导致 HBV 免疫被削弱。此外,我们发现趋化因子 CXCL13 参与 B 淋巴细胞的迁移和淋巴组织结构和发育,在成年小鼠和人肝巨噬细胞中呈年龄依赖性表达,并在促进针对 HBV 的有效免疫反应中发挥重要作用。总之,这些结果确定了有效控制 HBV 所需的一些免疫机制。